StocksMediumUpdated×2•Originally published 31 July 2026•Updated 31 July 2026•
1 min read

Colgate-Palmolive Shares Slip Despite EPS Beat as North American Demand Softens

Key Facts

1Colgate-Palmolive net sales increased 4.9% with organic sales growth of 2.4% in Q2 2026.
2GCL Global Holdings announced its financial results for the fiscal year ended March 31, 2026.
3Colgate-Palmolive GAAP gross profit margin increased 140 basis points to 61.5%.

In a shift reflecting cautious sentiment within the consumer staples sector, Colgate-Palmolive shares declined 2.5% despite exceeding quarterly earnings expectations. According to reports, the company delivered earnings per share (EPS) of $0.99, beating the $0.95 analyst estimate, on total revenue of $5.36 billion. However, the decision to reaffirm annual sales forecasts while citing softer demand in North America weighed on investor confidence.

The earnings beat was supported by a 4.9% rise in net sales and a significant gross margin expansion to 61.5%. This performance occurred alongside fiscal year results from GCL Global Holdings, highlighting broader activity among Nasdaq-listed entities. Per market data, these corporate developments coincide with a dip in US CB Consumer Confidence to 90.8, down from 92.2, suggesting a tightening environment for retail-facing brands.

In equity markets, CL stock stood at $92.73 at the close of July 28, 2026, retreating from an intraday high of $95.46. Investors are now watching for price stabilization following the 2.5% post-earnings slip, as the upcoming economic calendar shows no major high-impact catalysts directly tied to the instrument for the remainder of the week.

Latest Updates · 1

  1. Notable·

    Update: Supplemental data reveals that total net sales reached $5.36 billion, meeting analyst estimates, while non-GAAP earnings per share hit $0.99, exceeding expectations by 4.5%. Despite the earnings beat, CL shares experienced an immediate 2.6% decline following the announcement, indicating a mixed reaction from market participants.